Investigation of the Effect of Dietary Nitrate Treatment on Endothelial Function and Platelet Reactivity in Hypercholesterolemics.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1

Total Enrollment

69 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-08-31

Study Completion Date

2013-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Diets rich in fruit and vegetables reduce the risk of strokes and heart attacks, however the exact cause of this beneficial effect is uncertain. Evidence suggests that certain vegetables, including beetroot and the green leafy vegetables, possess high inorganic nitrate concentrations. The investigators recent evidence suggests that inorganic nitrate provides a source of gas called nitric oxide in the body that exerts a number of beneficial effects upon the heart and blood vessels . The investigators have previously shown that beetroot juice ingestion improves blood vessel (vascular endothelial) and platelet function in healthy volunteers. Studies by the investigators show that these effects are due to conversion of nitrate to nitrite by symbiotic (helpful) bacteria (located on the tongue) and subsequent conversion of nitrite to nitric oxide in blood vessels. The investigators now wish to explore whether dietary nitrate, via its beneficial effects on platelets and blood vessels, might improve indices of atherosclerotic disease progression in high risk individuals (hypercholesterolemics). Recruits will have high cholesterol and no known atherosclerosis and will not yet be on any anti-cholesterol medications. Volunteers will consume a daily dose of beetroot juice or placebo nitrate-free juice for six weeks. Vascular function will be assessed using non-invasive techniques at the beginning and at the end of the study using ultrasound measurement of flow mediated dilatation (FMD) of the brachial artery in the arm and pulse wave analysis (PWA) and pulse wave velocity (PWV) to measure arterial compliance. To assess impact on platelet function, blood samples will also be taken at the start and at the end of the study.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Impact of Inorganic Nitrate-rich Beetroot Juice on Microvascular Blood Flow and Cognitive Function

NCT05810974

Post Menopausal

COMPLETED NA

Effects of Daily Nitrate Consumption on Oral Bacteria Composition, Blood Pressure and Vascular Function

NCT03784742

No Dental Disease Non-smoking

COMPLETED NA

Dietary Nitrate and Healthy Older Adults

NCT03473678

Blood Pressure Cognitive Change Functional Capacity +1 more

COMPLETED NA

Evaluation of Adding Nitrate Into Foods for Regulating Nitric Oxide Bioavailability in Healthy Individuals

NCT07172425

Healthy Volunteers Nitric Oxide Vascular Function

RECRUITING NA

Effects of Dietary Nitrate From Vegetable/Fruit Juice on Cerebral Blood Flow Parameters

NCT01169662

Cerebrovascular Circulation Cognitive Impairment

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Please refer to brief summary.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypercholesterolemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Nitrate-rich beetroot juice

Six weeks once daily dose of nitrate rich beetroot juice

Group Type ACTIVE_COMPARATOR

beetroot juice

Intervention Type DIETARY_SUPPLEMENT

250mls daily beetroot juice

Nitrate deplete beetroot juice

six weeks daily dose beetroot juice (nitrate deplete)

Group Type PLACEBO_COMPARATOR

beetroot juice

Intervention Type DIETARY_SUPPLEMENT

250mls daily beetroot juice

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

beetroot juice

250mls daily beetroot juice

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Participants will be between 18-80 years of age.
2. They will be largely newly diagnosed patients with hypercholesterolemia (total serum cholesterol\>6.0mmol/L or any elevation of total cholesterol, LDL cholesterol or triglycerides with a QRISK 2 score \>15%).
3. We will include patients with familial hypercholesterolemia. These patients in general will either be managed in primary care alone or will attend the clinic following referral from general practitioners for further investigation following routine health tests.
4. In addition, patients who have been referred due to inability to tolerate statin treatment will be included.

Exclusion Criteria

Hypercholesterolemics will be screened by taking a medical history and physical examination, blood pressure measurement and urine sample taken to check for diabetes. The subject will continue his/her usual diet and exercise regime prior to diagnosis of hypercholesterolemia for purposes of this study. They will not be taking any additional vitamin or food supplements for the duration of the study.

1. A history of symptomatic ischemic heart disease (angina, previous myocardial infarction, acute coronary syndrome) or other known atherosclerosis.
2. A history of heart failure NYHA class 2-4 or severe LV dysfunction LVEF\<30% regardless of symptom status.
3. Use of statins within 2 months of screening visit.
4. A history of diabetes.
5. Systemic autoimmune disease such as rheumatoid arthritis, connective tissue disease, or other conditions known to be associated with chronic inflammation such as inflammatory bowel disease.
6. Any use of non steroidal anti-Inflammatory drugs, antiplatelet agents or steroids within two months of commencing study or likely future use required during the study.
7. Subjects with any acute infection, or significant trauma (burns, fractures).
8. Subjects who have donated \> 500mls blood within 56 days prior to study medication administration.
9. Anaemia with Hb \<10g/dl, or any other known blood disorder or significant illness that may affect platelet function, and coagulation. Known essential hypertension on antihypertensive medication is not a contraindication.
10. History of malignancy within the past 5 years other than non-melanoma skin cancer.
11. Any current life threatening condition including severe chronic obstructive airways disease, HIV infection, life threatening arrhythmia that may prevent subject completing the study.
12. Alcohol/drug abuse within the past 6 months of screening visit.
13. Excess alcohol consumption as defined as regular weekly consumption of \>28 units male and \>21 units female. (Department of Health Guidelines)
14. Use of an investigational device or investigational drug within 30 days or 5 half lives (whichever is longer) preceding the first dose of study medication.
15. Any non stable dosing of ongoing medication regimens throughout the study trial.
16. A history of chronic viral hepatitis (including presence of hepatitis B surface antigen or hepatitis C antibody or other chronic hepatic disorder.)
17. Abnormal liver function due to acute or chronic liver conditions 3 x upper limit of normal at screening.
18. Renal impairment with creatinine clearance (eGFR) of \<50ml/min at screening.
19. Pregnancy at time of screening or intention of getting pregnant during course of study.
20. Current smokers or ex smokers who stopped smoking \<3 months prior to administration of study medication.
21. BMI \<18.5 or \> or = 40kg/m2.

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No